Adage Capital Partners Gp, L.L.C. Day One Biopharmaceuticals, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$54.9 Billion
Q4 2024

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 800,000 shares of DAWN stock, worth $5.78 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

800,000

Previous 900,000 11.11%

Holding current value

$5.78 Million

Previous $12.5 Million 19.15%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$12.46 - $16.39 $1.25 Million - $1.64 Million	-100,000 Reduced 11.11%	800,000 $10.1 Million
Q3 2024 Nov 14, 2024	BUY	$12.72 - $16.03 $11.4 Million - $14.4 Million	900,000 New	900,000 $12.5 Million
Q1 2024 May 15, 2024	BUY	$13.56 - $17.46 $122,040 - $157,140	9,000 Added 6.0%	159,000 $2.63 Million
Q4 2023 Feb 14, 2024	SELL	$9.68 - $15.37 $8.58 Million - $13.6 Million	-886,599 Reduced 85.53%	150,000 $2.19 Million
Q3 2023 Nov 14, 2023	SELL	$11.22 - $14.86 $15.8 Million - $20.9 Million	-1,405,901 Reduced 57.56%	1,036,599 $12.7 Million
Q2 2023 Aug 14, 2023	BUY	$11.74 - $14.47 $20 Million - $24.6 Million	1,702,500 Added 230.07%	2,442,500 $29.2 Million
Q1 2023 May 15, 2023	SELL	$12.75 - $23.41 $32.6 Million - $59.9 Million	-2,560,000 Reduced 77.58%	740,000 $9.89 Million
Q4 2022 Feb 14, 2023	BUY	$18.77 - $22.0 $4.88 Million - $5.72 Million	260,000 Added 8.55%	3,300,000 $71 Million
Q3 2022 Nov 14, 2022	BUY	$16.44 - $26.57 $4.82 Million - $7.79 Million	293,175 Added 10.67%	3,040,000 $60.9 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $17.9 $14.7 Million - $46 Million	2,570,976 Added 1462.04%	2,746,825 $49.2 Million
Q1 2022 May 16, 2022	BUY	$9.12 - $17.47 $600,542 - $1.15 Million	65,849 Added 59.86%	175,849 $1.74 Million
Q4 2021 Feb 14, 2022	BUY	$15.65 - $26.33 $313,000 - $526,600	20,000 Added 22.22%	110,000 $1.85 Million
Q3 2021 Nov 15, 2021	BUY	$20.0 - $27.92 $1.8 Million - $2.51 Million	90,000 New	90,000 $2.14 Million

Others Institutions Holding DAWN

# of Institutions

176

Shares Held

77.1M

Call Options Held

139K

Put Options Held

253K

View Full List

About Day One Biopharmaceuticals, Inc.

Ticker DAWN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,461,104
Market Cap $530M
Description
Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...

More about DAWN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Day One Biopharmaceuticals, Inc. Transaction History